Advertisement

Topics

Jupiter Orphan Therapeutics Receives Orphan Drug Designation for its Trans-Resveratrol Product ...

08:45 EDT 22 Aug 2017 | BioMedReports - Blog

JUPITER, Fla., Aug. 22, 2017/PRNewswire/ -- Jupiter Orphan Therapeutics, Inc. ("JOT"), Jupiter, FL, today announced that it has received notification from the US

Read more...

Original Article: Jupiter Orphan Therapeutics Receives Orphan Drug Designation for its Trans-Resveratrol Product ...

NEXT ARTICLE

More From BioPortfolio on "Jupiter Orphan Therapeutics Receives Orphan Drug Designation for its Trans-Resveratrol Product ..."

Advertisement
Quick Search
Advertisement
Advertisement